EUVIMEDEUVIMED entdecken
Open Access

Nosocomial SARS-CoV-2 Infections and Mortality During Unique COVID-19 Epidemic Waves

Nishi Dave, Daniel Sjöholm, Pontus Hedberg, Anders Ternhag, Fredrik Granath, Janneke D M Verberk, Anders F Johansson, Suzanne D van der Werff, Pontus Nauclér

JAMA Network Open · 2023

DOI: 10.1001/jamanetworkopen.2023.41936 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, 2023. Verfasst von Nishi Dave und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Solna, Division of Infectious Diseases, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: COVID-19, Cross Infection. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Quantifying the burden of nosocomial SARS-CoV-2 infections and associated mortality is necessary to assess the need for infection prevention and control measures.

Objective

To investigate the occurrence of nosocomial SARS-CoV-2 infections and associated 30-day mortality among patients admitted to hospitals in Region Stockholm, Sweden. Design, Setting, and Participants A retrospective, matched cohort study divided the period from March 1, 2020, until September 15, 2022, into a prevaccination period, early vaccination and pre-Omicron (period 1), and late vaccination and Omicron (period 2). From among 303 898 patients 18 years or older living in Region Stockholm, 538 951 hospital admissions across all hospitals were included. Hospitalized admissions with nosocomial SARS-CoV-2 infections were matched to as many as 5 hospitalized admissions without nosocomial SARS-CoV-2 by age, sex, length of stay, admission time, and hospital unit. Exposure Nosocomial SARS-CoV-2 infection defined as the first positive polymerase chain reaction test result at least 8 days after hospital admission or within 2 days after discharge. Main Outcomes and Measures Primary outcome of 30-day mortality was analyzed using time-to-event analyses with a Cox proportional hazards regression model adjusted for age, sex, educational level, and comorbidities.

Results

Among 2193 patients with SARS-CoV-2 infections or reinfections (1107 women [50.5%]; median age, 80 [IQR, 71-87] years), 2203 nosocomial SARS-CoV-2 infections were identified. The incidence rate of nosocomial SARS-CoV-2 infections was 1.57 (95% CI, 1.51-1.64) per 1000 patient-days. In the matched cohort, 1487 hospital admissions with nosocomial SARS-CoV-2 infections were matched to 5044 hospital admissions without nosocomial SARS-CoV-2 infections. Thirty-day mortality was higher in the prevaccination period (adjusted hazard ratio [AHR], 2.97 [95% CI, 2.50-3.53]) compared with period 1 (AHR, 2.08 [95% CI, 1.50-2.88]) or period 2 (AHR, 1.22 [95% CI, 0.92-1.60]). Among patients with nosocomial SARS-CoV-2 infections, 30-day AHR comparing those with 2 or more doses of SARS-CoV-2 vaccination and those with less than 2 doses was 0.64 (95% CI, 0.46-0.88). Conclusions and Relevance In this matched cohort study, nosocomial SARS-CoV-2 infections were associated with higher 30-day mortality during the early phases of the pandemic and lower mortality during the Omicron variant wave and after the introduction of vaccinations. Mitigation of excess mortality risk from nosocomial transmission should be a strong focus when population immunity is low through implementation of adequate infection prevention and control measures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Cross InfectionHumansFemaleAged, 80 and overSARS-CoV-2COVID-19 VaccinesCohort StudiesRetrospective StudiesHospitalsPandemics

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Medicine, Solna, Division of Infectious Diseases, Karolinska Institutet, Stockholm, Sweden.
  • Department of Medicine, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.
  • Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Medical Microbiology and Infection Prevention, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Department of Epidemiology, Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Department of Clinical Microbiology and Laboratory for Molecular Infection Medicine Sweden, Umeå University, Umeå, Sweden.

Zitieren

APA

Dave, N., Sjöholm, D., Hedberg, P., Ternhag, A., Granath, F., Verberk, J. D. M., Johansson, A. F., van der Werff, S. D., & Nauclér, P. (2023). Nosocomial SARS-CoV-2 Infections and Mortality During Unique COVID-19 Epidemic Waves. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2023.41936

Vancouver

Dave N, Sjöholm D, Hedberg P, Ternhag A, Granath F, Verberk JDM, et al. Nosocomial SARS-CoV-2 Infections and Mortality During Unique COVID-19 Epidemic Waves. JAMA Network Open. 2023. doi:10.1001/jamanetworkopen.2023.41936

BibTeX
@article{Dave2023,
  author = {Dave, Nishi and Sjöholm, Daniel and Hedberg, Pontus and Ternhag, Anders and Granath, Fredrik and Verberk, Janneke D M and Johansson, Anders F and van der Werff, Suzanne D and Nauclér, Pontus},
  title = {Nosocomial SARS-CoV-2 Infections and Mortality During Unique COVID-19 Epidemic Waves},
  journal = {JAMA Network Open},
  year = {2023},
  doi = {10.1001/jamanetworkopen.2023.41936}
}
Kostenlos starten →